학술논문
A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial
Document Type
Article
Author
Source
In: Gastric Cancer . (Gastric Cancer, July 2022, 25(4):783-793)
Subject
Language
English
ISSN
14363305
14363291
14363291